These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3910194)

  • 1. Clinical correlations with the human tumor cloning assay.
    Hanauske AR; Von Hoff DD
    Cancer Invest; 1985; 3(6):541-51. PubMed ID: 3910194
    [No Abstract]   [Full Text] [Related]  

  • 2. The human tumor cloning assay in cancer research and therapy: a review with clinical correlations.
    Hanauske AR; Hanauske U; Von Hoff DD
    Curr Probl Cancer; 1985 Dec; 9(12):1-66. PubMed ID: 2419036
    [No Abstract]   [Full Text] [Related]  

  • 3. Amsacrine (AMSA)--a clinical review.
    Louie AC; Issell BF
    J Clin Oncol; 1985 Apr; 3(4):562-92. PubMed ID: 3884748
    [No Abstract]   [Full Text] [Related]  

  • 4. How to use cancer chemotherapy.
    Dollinger MR
    Am Fam Physician; 1971 Jun; 3(6):73-84. PubMed ID: 4325596
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro chemosensitivities of human tumor stem cells to the Phase II drug 4'-(9-acridinylamino)methanesulfon-m-anisidide and prospective in vivo correlations.
    Ahmann FR; Meyskens FL; Moon TE; Durie BG; Salmon SE
    Cancer Res; 1982 Nov; 42(11):4495-8. PubMed ID: 6897012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer treatment today and its impact on drug development, with special emphasis on the phase II clinical trial.
    Carter SK
    J Natl Cancer Inst; 1976 Aug; 57(2):235-44. PubMed ID: 794496
    [No Abstract]   [Full Text] [Related]  

  • 7. m-AMSA: an exciting new drug in the National Cancer Institute Drug Development Program.
    Weiss RB; Charles LM; Macdonald JS
    Cancer Clin Trials; 1980; 3(3):203-9. PubMed ID: 7002337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective clinical trial of a human tumor cloning system.
    Von Hoff DD; Clark GM; Stogdill BJ; Sarosdy MF; O'Brien MT; Casper JT; Mattox DE; Page CP; Cruz AB; Sandbach JF
    Cancer Res; 1983 Apr; 43(4):1926-31. PubMed ID: 6339044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of clinical trials of m-AMSA, dihydroxyanthracenedione, and deoxycoformycin.
    Macdonald JS; Marsoni S; Bruno S; Poster D
    Recent Results Cancer Res; 1982; 80():323-30. PubMed ID: 6977170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of tumor colony assay in clinical oncology.
    Niell HB; Neely CL; Wood CA; Soloway MS; Maxwell TA; Buxton BH; Dilawari RA; Kim WS
    South Med J; 1983 Nov; 76(11):1376-9. PubMed ID: 6635726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interferon in antitumoral chemotherapy].
    Soria M
    Recenti Prog Med; 1981 May; 70(5):494-523. PubMed ID: 6171850
    [No Abstract]   [Full Text] [Related]  

  • 12. Individualized patient chemotherapy: use of a human tumor colony formation technique.
    Meyskens FL
    Front Radiat Ther Oncol; 1981; 16():55-61. PubMed ID: 7199500
    [No Abstract]   [Full Text] [Related]  

  • 13. Re-evaluation of methotrexate as an anticancer drug.
    Sullivan RD; Miller E; Zurek WZ; Oberfield RA; Ojima Y
    Surg Gynecol Obstet; 1967 Oct; 125(4):819-24. PubMed ID: 6041727
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy in metastatic melanoma: phase II studies of amsacrine, mitoxantrone and bisantrene.
    Coates AS; Bishop J; Mann GJ; Raghavan D
    Eur J Cancer Clin Oncol; 1986 Jan; 22(1):97-100. PubMed ID: 3754214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer chemotherapy.
    Smith LH
    Major Probl Intern Med; 1971; 1():1-197. PubMed ID: 5005758
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase I clinical investigation of 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride with correlative in vitro human tumor clonogenic assay.
    Alberts DS; Mackel C; Pocelinko R; Salmon SE
    Cancer Res; 1982 Mar; 42(3):1170-5. PubMed ID: 7037174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of metastatic ovarian carcinoma with amsacrine: a cancer and leukemia group B phase II study.
    Amrein PC; Coleman M; Richards F; Bhardwaj S; Kennedy BJ; Haurani FI; Frelick RW; Pastmantier MW; Herschkopf R
    Cancer Treat Rep; 1984 Nov; 68(11):1397-8. PubMed ID: 6548660
    [No Abstract]   [Full Text] [Related]  

  • 18. New cytotoxic drugs for breast cancer and their clinical evaluation.
    Carter SK
    Eur J Cancer (1965); 1980; Suppl 1():265-70. PubMed ID: 6459235
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase II evaluation of PALA and AMSA for patients with disseminated malignant melanoma.
    Creagan ET; Ahmann DL; Ingle JN; Purvis JD; Green SJ
    Cancer Treat Rep; 1981; 65(1-2):169. PubMed ID: 6894400
    [No Abstract]   [Full Text] [Related]  

  • 20. Interferons in the management of multiple myeloma.
    Cooper MR
    Semin Oncol; 1988 Oct; 15(5 Suppl 5):21-5. PubMed ID: 3057642
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.